These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11289134)

  • 21. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
    Joseph LF; Ezhevsky S; Scott DW
    Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: inhibition by proliferating osteoblasts and osteosarcoma cells.
    Smith E; Frenkel B; MacLachlan TK; Giordano A; Stein JL; Lian JB; Stein GS
    J Cell Biochem; 1997 Aug; 66(2):141-52. PubMed ID: 9213216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
    Cao W; Chi WH; Wang J; Tang JJ; Lu YJ
    Biochem Biophys Res Commun; 2005 May; 330(4):1034-40. PubMed ID: 15823547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels.
    Jiang H; Karnezis AN; Tao M; Guida PM; Zhu L
    Oncogene; 2000 Aug; 19(34):3878-87. PubMed ID: 10951581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
    Nakayama T; Hashimoto Y; Kaneko Y; Kurokawa K
    Biochem Biophys Res Commun; 1996 Jul; 224(1):180-3. PubMed ID: 8694809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide.
    Ma Y; Prigent SA; Born TL; Monell CR; Feramisco JR; Bertolaet BL
    Cancer Res; 1999 Oct; 59(20):5341-8. PubMed ID: 10537318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
    Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
    Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
    Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis.
    Lukas J; Sørensen CS; Lukas C; Santoni-Rugiu E; Bartek J
    Oncogene; 1999 Jul; 18(27):3930-5. PubMed ID: 10435615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity.
    Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI
    Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
    Mendoza N; Fong S; Marsters J; Koeppen H; Schwall R; Wickramasinghe D
    Cancer Res; 2003 Mar; 63(5):1020-4. PubMed ID: 12615717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway.
    Nguyen DM; Schrump WD; Tsai WS; Chen A; Stewart JH; Steiner F; Schrump DS
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1132-42. PubMed ID: 12771887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
    Raju U; Nakata E; Mason KA; Ang KK; Milas L
    Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells.
    Lane ME; Yu B; Rice A; Lipson KE; Liang C; Sun L; Tang C; McMahon G; Pestell RG; Wadler S
    Cancer Res; 2001 Aug; 61(16):6170-7. PubMed ID: 11507069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
    Rideout HJ; Wang Q; Park DS; Stefanis L
    J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
    Zhang W; Lee JC; Kumar S; Gowen M
    J Bone Miner Res; 1999 Apr; 14(4):528-35. PubMed ID: 10234573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation.
    Brugarolas J; Moberg K; Boyd SD; Taya Y; Jacks T; Lees JA
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1002-7. PubMed ID: 9927683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway.
    Alonso M; Tamasdan C; Miller DC; Newcomb EW
    Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.